Average Co-Inventor Count = 3.93
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ironwood Pharmaceuticals, Inc. (24 from 44 patents)
2. Sepracor, Inc. (13 from 322 patents)
3. G.d. Searle & Company (11 from 1,323 patents)
4. Sunovion Pharmaceuticals Inc. (10 from 130 patents)
5. Cyclerion Therapeutics, Inc. (4 from 24 patents)
6. Microbia, Inc. (4 from 12 patents)
7. Other (1 from 832,680 patents)
8. Monsanto Company (1 from 3,288 patents)
9. Pharmacia Corporation (1 from 200 patents)
10. Ironwood Pharmaceutical, Inc. (1 from 1 patent)
11. Forest Laboratories Holdings Limited (26 patents)
70 patents:
1. 11357777 - Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)
2. 11207323 - sGC stimulators
3. 10702486 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
4. 10639308 - sGC stimulators
5. 10618938 - Compositions for colon cleansing and the treatment of gastrointestinal disorders
6. 10517874 - sGC stimulators
7. 10328036 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
8. 10183021 - sGC stimulators
9. 9907764 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
10. 9840536 - Methods and compositions for the treatment of gastrointestinal disorders
11. 9650417 - Treatments for gastrointestinal disorders
12. 9617305 - Treatments for gastrointestinal disorders
13. 9586937 - sGC stimulators
14. 9527887 - Treatments for gastrointestinal disorders
15. 9498452 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine